Let's advance precision pathologytogether
We collaborate with clinical and preclinical research partners, and with platform and scanner vendors, to deliver a seamless deployment of our computational pathology solutions for our clients.
- Validated on partner cohorts
- ISO 13485 certified quality management system
- Running inside the platforms laboratories already use

Advancing preclinical pathology with TNO
TNO brings the preclinical and pharmaceutical research expertise and we bring the AI. We apply our models within TNO's preclinical studies, across several of their study areas, with more in development.
The exchange runs in both directions: we validate our models on TNO's research facilities and network, and our AI expertise strengthens their preclinical contract research.
Aiosyn exemplifies the kind of bold, forward-thinking innovation that TNO is proud to support, delivering on TNO's strategy to help Dutch tech companies scale globally and lead in key technologies.
Hans BoumansDirector of TNO VenturesWho we work with
Clinical departments, preclinical CROs, and the platform and scanner vendors who carry the analyses into the systems laboratories already use.


- Latest news: Automating their slide quality control

- Latest news: The published dapagliflozin study

- Latest news: NephroPath on Sectra Amplifier

- Latest news: Integrated into Techcyte Fusion

- Latest news: Real-time processing on the scanner

- Latest news: Kidney analysis on PathologyMap

- Latest news: Evaluating mitosis detection

- Latest news: Eurostars grant for renal diagnostics








Bring us a collaboration
A cohort to validate a model on, a platform to carry the analyses into, or a read-out the suite does not cover yet. Tell us which, and we will tell you whether we are the right partner for it.